April Barnard

Patent Agent

Overview

Over the course of a decade working in the surgical field, April Barnard's research career began in cardiovascular physiology before shifting focus to microbiology and immunology. As a result, she has particular knowledge in several areas of biomedical science, including surgical equipment, vaccine development, and genetic engineering.

While working closely with anesthesiologists in the operating room, April published research in cardiovascular surgical outcomes. Throughout her undergraduate career, she gained experience in several areas ranging from botany to stem-cell research. After graduating from Indiana University with degrees in biology and chemistry, she entered Indiana University School of Medicine’s biomedical science Ph.D. program. As a graduate student, April performed cardiovascular surgery in large animal models, implemented molecular genetic manipulation using such techniques as PCR and CRISPR-Cas9, and focused on the effects of biological sex on viral pathogenesis.

In addition to biomedical research, April is passionate about science education and science literacy, devoting time and energy to teach undergraduate microbiology. With the mission to protect scientific integrity and advocate for those working in biomedical research, she served as president of her graduate class and founded science outreach organizations. April has additional experience working with organic and inorganic chemistry.

Career & Education

|
    • Indiana University School of Medicine
      Research Scientist, October 2015 – May 2020
    • Ivy Tech Community College
      Adjunct Instructor, Microbiology, August 2016 – July 2020
    • Indiana State Department of Health
      Policy Intern, November 2019 – January 2019
    • Kentucky One Health, Jewish Hospital
      Anesthesia Technician, August 2012 – May 2015
    • Indiana University School of Medicine
      Research Scientist, October 2015 – May 2020
    • Ivy Tech Community College
      Adjunct Instructor, Microbiology, August 2016 – July 2020
    • Indiana State Department of Health
      Policy Intern, November 2019 – January 2019
    • Kentucky One Health, Jewish Hospital
      Anesthesia Technician, August 2012 – May 2015
    • Indiana University, A.A., Chemistry, 2015
    • Indiana University, B.S., Biology, 2015
    • Indiana University School of Medicine, M.S., Microbiology & Immunology, 2020
    • Indiana University, A.A., Chemistry, 2015
    • Indiana University, B.S., Biology, 2015
    • Indiana University School of Medicine, M.S., Microbiology & Immunology, 2020
    • U.S. Patent and Trademark Office (USPTO)
    • U.S. Patent and Trademark Office (USPTO)
  • Professional Activities and Memberships

    • American Association for the Advancement of Science, Member
    • American Society for Virology, Member

    Professional Activities and Memberships

    • American Association for the Advancement of Science, Member
    • American Society for Virology, Member

April's Insights

Client Alert | 2 min read | 01.11.24

Enabling Practitioners: USPTO Issues Guidelines for Assessing Enablement Post-Amgen

On January 10, 2024, the United States Patent and Trademark Office (USPTO) published Guidelines for assessing enablement after the Supreme Court’s recent decision in Amgen Inc. et al. v. Sanofi et al.  The Guidelines inform Examiners and the public on the Office’s implementation of the Amgen opinion. In sum, the Guidelines maintain the status quo.   ...

Recognition

  • Indiana University: McKinney Brinks Gilson & Lione IP Law Scholar, 2020
  • Indiana University: Undergraduate Student Research Fellowship, 2015
  • James Y. McCullough Scholarship, 2015

April's Insights

Client Alert | 2 min read | 01.11.24

Enabling Practitioners: USPTO Issues Guidelines for Assessing Enablement Post-Amgen

On January 10, 2024, the United States Patent and Trademark Office (USPTO) published Guidelines for assessing enablement after the Supreme Court’s recent decision in Amgen Inc. et al. v. Sanofi et al.  The Guidelines inform Examiners and the public on the Office’s implementation of the Amgen opinion. In sum, the Guidelines maintain the status quo.   ...

April's Insights

Client Alert | 2 min read | 01.11.24

Enabling Practitioners: USPTO Issues Guidelines for Assessing Enablement Post-Amgen

On January 10, 2024, the United States Patent and Trademark Office (USPTO) published Guidelines for assessing enablement after the Supreme Court’s recent decision in Amgen Inc. et al. v. Sanofi et al.  The Guidelines inform Examiners and the public on the Office’s implementation of the Amgen opinion. In sum, the Guidelines maintain the status quo.   ...